Moreover, it has been reported that Gln may have an antioxidant and anti-inflammatory activity in patients with IBD (47), by reducing the production of several proinflammatory cytokines (IL-8 and IL-6) and enhancing the production of the anti-inflammatory IL-10 in patients with CD (9). This evidence concerns the gene IL10 and inflammatory bowel disease.